메뉴 건너뛰기




Volumn 55, Issue 11, 2016, Pages 2033-2039

The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: Results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

(37)  Silva Fernández, Lucía a,b   Lunt, Mark a   Kearsley Fleet, Lianne a   Watson, Kath D a   Dixon, William G a,c   Symmons, Deborah P M a   Hyrich, Kimme L a,c,r   Maiden, Nicola d   Price, Tom e   Hopkinson, Neil f   O'Reilly, Sheila g   Hordon, Lesley h   Griffiths, Ian i   Porter, Duncan j   Capell, Hilary k   Hassell, Andy l   Benitha, Romela m   Choy, Ernest n   Walsh, David o   Emery, Paul p   more..


Author keywords

Anti TNF; Cancer; Cohort study; Rheumatoid arthritis; Rituximab

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; RITUXIMAB; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; BIOLOGICAL PRODUCT; TUMOR NECROSIS FACTOR;

EID: 84997181483     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew314     Document Type: Article
Times cited : (65)

References (21)
  • 1
    • 0036484856 scopus 로고    scopus 로고
    • Chronic inflammation and cancer
    • discussion 230-2
    • Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology 2002;16:217-26, 229; discussion 230-2.
    • (2002) Oncology , vol.16
    • Shacter, E.1    Weitzman, S.A.2
  • 2
    • 44349093644 scopus 로고    scopus 로고
    • Cancer in rheumatoid arthritis: Occurrence, mortality, and associated factors in a South European population
    • Abasolo L, Judez E, Descalzo MA et al. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum 2008;37:388-97.
    • (2008) Semin Arthritis Rheum , vol.37 , pp. 388-397
    • Abasolo, L.1    Judez, E.2    Descalzo, M.A.3
  • 4
    • 2642554059 scopus 로고    scopus 로고
    • Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
    • Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-51.
    • (2004) Arthritis Rheum , vol.50 , pp. 1740-1751
    • Wolfe, F.1    Michaud, K.2
  • 5
    • 67549122368 scopus 로고    scopus 로고
    • Etanercept therapy in rheumatoid arthritis and the risk of malignancies: A systematic review and individual patient data meta-analysis of randomised controlled trials
    • Bongartz T, Warren FC, Mines D et al. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. Ann Rheum Dis 2009;68:1177-83.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1177-1183
    • Bongartz, T.1    Warren, F.C.2    Mines, D.3
  • 6
    • 67549117204 scopus 로고    scopus 로고
    • The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: Meta and exposure-adjusted pooled analyses of serious adverse events
    • Leombruno JP, Einarson TR, Keystone EC. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Ann Rheum Dis 2009;68:1136-45.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1136-1145
    • Leombruno, J.P.1    Einarson, T.R.2    Keystone, E.C.3
  • 7
    • 27744527575 scopus 로고    scopus 로고
    • Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
    • Askling J, Fored CM, Brandt L et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1421-6.
    • (2005) Ann Rheum Dis , vol.64 , pp. 1421-1426
    • Askling, J.1    Fored, C.M.2    Brandt, L.3
  • 8
    • 84860915531 scopus 로고    scopus 로고
    • The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: Longitudinal results from the British Society for Rheumatology Biologics Register
    • Mercer LK, Green AC, Galloway JB et al. The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2012;71:869-74.
    • (2012) Ann Rheum Dis , vol.71 , pp. 869-874
    • Mercer, L.K.1    Green, A.C.2    Galloway, J.B.3
  • 9
    • 84877633711 scopus 로고    scopus 로고
    • Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: Nationwide population based prospective cohort study from Sweden
    • Raaschou P, Simard JF, Holmqvist M, Askling J, Group AS. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden. BMJ 2013;346:f1939.
    • (2013) BMJ , vol.346 , pp. f1939
    • Raaschou, P.1    Simard, J.F.2    Holmqvist, M.3    Askling, J.4    Group, A.S.5
  • 10
    • 77953103015 scopus 로고    scopus 로고
    • Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for Rheumatology Biologics Register
    • Dixon WG, Watson KD, Lunt M et al. Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register. Arthritis Care Res 2010;62:755-63.
    • (2010) Arthritis Care Res , vol.62 , pp. 755-763
    • Dixon, W.G.1    Watson, K.D.2    Lunt, M.3
  • 11
    • 77955479672 scopus 로고    scopus 로고
    • Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
    • Strangfeld A, Hierse F, Rau R et al. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT. Arthritis Res Ther 2010;12:R5.
    • (2010) Arthritis Res Ther , vol.12 , pp. R5
    • Strangfeld, A.1    Hierse, F.2    Rau, R.3
  • 12
    • 0032530342 scopus 로고    scopus 로고
    • Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study
    • Coiffier B, Haioun C, Ketterer N et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998;92:1927-32.
    • (1998) Blood , vol.92 , pp. 1927-1932
    • Coiffier, B.1    Haioun, C.2    Ketterer, N.3
  • 13
    • 66149084485 scopus 로고    scopus 로고
    • Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: Relative risks and time trends in the Swedish Biologics Register
    • Askling J, Baecklund E, Granath F et al. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis 2009;68:648-53.
    • (2009) Ann Rheum Dis , vol.68 , pp. 648-653
    • Askling, J.1    Baecklund, E.2    Granath, F.3
  • 14
    • 84865692521 scopus 로고    scopus 로고
    • Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: A meta-analysis
    • Lopez-Olivo MA, Tayar JH, Martinez-Lopez JA et al. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA 2012;308:898-908.
    • (2012) JAMA , vol.308 , pp. 898-908
    • Lopez-Olivo, M.A.1    Tayar, J.H.2    Martinez-Lopez, J.A.3
  • 16
    • 84871127807 scopus 로고    scopus 로고
    • Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
    • Mercer LK, Davies R, Galloway JB et al. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology 2013;52:91-8.
    • (2013) Rheumatology , vol.52 , pp. 91-98
    • Mercer, L.K.1    Davies, R.2    Galloway, J.B.3
  • 17
    • 84932606892 scopus 로고    scopus 로고
    • Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    • Mercer LK, Lunt M, Low AL et al. Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 2015;74:1087-93.
    • (2015) Ann Rheum Dis , vol.74 , pp. 1087-1093
    • Mercer, L.K.1    Lunt, M.2    Low, A.L.3
  • 18
    • 33644892763 scopus 로고    scopus 로고
    • Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
    • Baecklund E, Iliadou A, Askling J et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692-701.
    • (2006) Arthritis Rheum , vol.54 , pp. 692-701
    • Baecklund, E.1    Iliadou, A.2    Askling, J.3
  • 19
    • 33845342915 scopus 로고    scopus 로고
    • Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics
    • Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 2006;15:2069-77.
    • (2006) Cancer Epidemiol Biomarkers Prev , vol.15 , pp. 2069-2077
    • Smedby, K.E.1    Baecklund, E.2    Askling, J.3
  • 20
    • 70349464351 scopus 로고    scopus 로고
    • Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity
    • Hyrich KL, Deighton C, Watson KD et al. Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity. Rheumatology 2009;48:1323-7.
    • (2009) Rheumatology , vol.48 , pp. 1323-1327
    • Hyrich, K.L.1    Deighton, C.2    Watson, K.D.3
  • 21
    • 84856548244 scopus 로고    scopus 로고
    • Effectiveness of rituximab in patients with rheumatoid arthritis: Observational study from the British Society for Rheumatology Biologics Register
    • Soliman MM, Hyrich KL, Lunt M et al. Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics Register. J Rheumatol 2012;39:240-6.
    • (2012) J Rheumatol , vol.39 , pp. 240-246
    • Soliman, M.M.1    Hyrich, K.L.2    Lunt, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.